Expression of this cell surface glycoprotein also led to activation of the ERK MAPK pathway promoting cell cycle progression by increasing the levels of cyclin D1 and cyclin E in the murine pancreatic adenocarcinoma cell line Panc02. The gene discussed is CCND1; the disease is pancreatic adenocarcinoma.